Home LiteratureArticle Details
PMID: 6979608 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections.

The Journal of experimental medicine ·Vol. 156 ·No. 1 ·1982-07-01 ·Pages 79-89

Pfau CJ, Valenti JK, Pevear DC, Hunt KD

Abstract

Two types of lymphocytic choriomeningitis (LCM) viruses were studied which, upon intracerebral injection into adult C3H mice, provoked either (a) acute fatal central nervous system (CNS) disease or (b) life-long persistent infection. Both virus types, (a) aggressive and (b) docile, had been found to induce LCM-specific lymphocytes with comparable in vitro lytic activity (11). Because the requirement for T cells in the development of adult LCM disease has been extensively documented, we sought other reasons for the lack of acute disease in mice infected with docile virus. A striking correlation was found between the outcome of the infection and spread of virus to visceral organs. Adoptive transfer experiments showed that a 300-plaque forming unit inoculum of docile virus induced a population of T cells in donor mice fully capable of causing CNS disease in identically infected recipients. This disease causing ability was lost if the interaction was delayed beyond 3 d after infection of the recipients, but could be preserved by lowering the size of the viral inoculum in the recipients. Furthermore, without adoptive transfer, very low intracerebral doses of docile virus (which mimicked the normally slow spread of aggressive virus) were lethal. On the other hand, very high doses of aggressive virus, which mimicked the normally rapid spread of docile virus, did not induce fatal CNS disease. The results suggest that rapid dissemination of the LCM infection creates multiple target organs which divert the focused lethal T cell attack on the brain.

MeSH Terms
Animals Cyclophosphamide/therapeutic use Cytotoxicity, Immunologic Female Immunization, Passive Lymphocytic Choriomeningitis/drug therapy,immunology,mortality Lymphocytic choriomeningitis virus/growth & development,immunology,pathogenicity Mice Mice, Inbred BALB C Mice, Inbred C3H T-Lymphocytes/immunology Viral Plaque Assay
Chemicals
Cyclophosphamide
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pfau C J
Valenti J K
Pevear D C
Hunt K D
References (21)
21 references, click to expand
  1. The virology and immunobiology of lymphocytic choriomeningitis virus infection.
    Adv Immunol. 1980;30:275-331 PMID: 6160740
  2. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    J Immunol. 1975 Jan;114(1 Pt 1):30-3 PMID: 1078677
  3. THE PATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS IN MICE: THE EFFECTS OF DIFFERENT INOCULATION ROUTES AND THE FOOTPAD RESPONSE.
    J Immunol. 1963 Oct;91:460-8 PMID: 14082033
  4. Cytotoxic T cells are induced in mice infected with lymphocytic choriomeningitis virus strains of markedly different pathogenicities.
    Infect Immun. 1982 May;36(2):598-602 PMID: 6979512
  5. Lack of B-cell participation in acute lymphocyte choriomeningitis disease of the central nervous system.
    Cell Immunol. 1978 Mar 1;36(1):143-50 PMID: 305287
  6. Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis.
    J Exp Med. 1973 Nov 1;138(5):1266-9 PMID: 4542807
  7. Interferon induction by lymphocytic choriomeningitis viruses correlates with maximum virulence.
    J Gen Virol. 1981 Dec;57(Pt 2):275-83 PMID: 6172554
  8. H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.
    J Exp Med. 1975 Feb 1;141(2):502-7 PMID: 123002
  9. STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS.
    Acta Pathol Microbiol Scand. 1964;61:268-82 PMID: 14162804
  10. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.
    J Exp Med. 1972 Apr 1;135(4):874-89 PMID: 4622913
  11. Dose-response relationships of lymphocytic choriomeningitis viruses in mice and L cell tube cultures.
    J Hyg (Lond). 1969 Jun;67(2):269-78 PMID: 4978938
  12. PROTECTIVE EFFECT OF NEONATAL THYMECTOMY ON MOUSE LCM INFECTION.
    Proc Soc Exp Biol Med. 1963 Oct;114:248-51 PMID: 14076900
  13. Initiation of persistent lymphocytic choriomeningitis infection in adult mice.
    J Infect Dis. 1971 Jun;123(6):603-10 PMID: 4999906
  14. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.
    Adv Immunol. 1979;27:51-177 PMID: 92183
  15. Intracerebral injections and the growth of viruses in the mouse brain.
    Br J Exp Pathol. 1960 Feb;41:52-9 PMID: 14422710
  16. Immune responses to LCM virus infection in vivo and in vitro. Mechanisms of immune-mediated disease.
    Bull World Health Organ. 1975;52(4-6):465-70 PMID: 1085206
  17. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease.
    Nature. 1972 Aug 11;238(5363):335-7 PMID: 4561841
  18. Determinants of spontaneous recovery and persistance in MDCK cells infected with lymphocytic choriomeningitis virus.
    J Gen Virol. 1979 Jul;44(1):113-22 PMID: 501333
  19. Public Health Weekly Reports for JANUARY 10, 1936.
    Public Health Rep. 1936 Jan 10;51(2):29-52 PMID: 19315538
  20. Viral pathogenesis and resistance to defective interfering particles.
    Nature. 1980 Jan 17;283(5744):311-3 PMID: 7352005
  21. Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon.
    J Exp Med. 1980 Sep 1;152(3):633-40 PMID: 6157772
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1982-07-01
Pages
79-89
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2186718
Subset
IM
Grants
NIAID NIH HHS · AI-16562 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com